MSH|^~\&|HEXALIS|TEST|CERBA|EDS|20241023131001||ORU^R01^ORU_R01|202410231310011956|P|2.5.1|241023131001957||||FRA|8859/15|FR||05.00-104285^HEXALISPID|1||~C3020900013^^^HEXALIS&ETALON3_QUALIF500^LOCAL||TNB70^JEAN-MICHEL^^^MR^^D~TRANSMIS^JEAN-MICHEL^TEST^^MR^^L|TRANSMIS|19770714|F|||||||||||||||||1|||||||VALIORC|SC|C3020900006_GLYW5^HEXALIS^ETALON3_HEXATEST|C3020900013_GLY^HEXALIS^ETALON3_QUALIF500|C3020900006^HEXALIS^ETALON3_HEXATEST|CM||^^^20230209180600||20230209175700||||||20230209OBR|1|C3020900006_GLYW5^HEXALIS^ETALON3_HEXATEST|C3020900013_GLY^HEXALIS^ETALON3_QUALIF500|GLY^GLYCEMIE A JEUN^HEXALIS-ETALON3_QUALIF500|||20230209180600|||||||20230209175700|||||||||||F|||||||||||20230209TQ1|||||||||ROBX|1|NM|GLY--test^Glycémie^HEXALIS-ETALON3_QUALIF500^GLY^Glycémie (1)||1.00|g/L^^HEXALIS-ETALON3_QUALIF500|      0,65 à 1,10|N|||F|||20230209180133||JM^DR MARTIN Jean-PierreOBX|2|NM|GLY-converti--test^Glycémie - converti^HEXALIS-ETALON3_QUALIF500^GLY^Glycémie (1)||5.55|mmol/L^^HEXALIS-ETALON3_QUALIF500|3,61 à 6,10|N|||F|||20230209180133||JM^DR MARTIN Jean-PierreORC|SC|C3020900006_ACESW^HEXALIS^ETALON3_HEXATEST|C3020900013_ACE^HEXALIS^ETALON3_QUALIF500|C3020900006^HEXALIS^ETALON3_HEXATEST|CM||^^^20230209180600||20230209175700||||||20230209OBR|2|C3020900006_ACESW^HEXALIS^ETALON3_HEXATEST|C3020900013_ACE^HEXALIS^ETALON3_QUALIF500|ACE^A.C.E.^HEXALIS-ETALON3_QUALIF500|||20230209180600|||||||20230209175700|||||||||||F|||||||||||20230209TQ1|||||||||ROBX|1|NM|ACE--test^A.C.E.^HEXALIS-ETALON3_QUALIF500^ACE^Antigène Carcino-embryonnaire||4.0|µg/L^^HEXALIS-ETALON3_QUALIF500|      Inf. à 5,0|N|||F|||20230209180134||JM^DR MARTIN Jean-Pierre